Proteomic analysis of combined IGF1 receptor targeted therapy and chemotherapy identifies signatures associated with survival in breast cancer patients

Clinical, epidemiological and experimental data identified the insulin-like growth factor-1 receptor (IGF1R) as a candidate therapeutic target in oncology. While this paradigm is based on well-established biological facts, including the potent anti-apoptotic and cell survival capabilities of the rec...

Descripción completa

Detalles Bibliográficos
Autores principales: Sinai-Livne, Tali, Pasmanik-Chor, Metsada, Cohen, Zoya, Tsarfaty, Ilan, Werner, Haim, Berger, Raanan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7197451/
https://www.ncbi.nlm.nih.gov/pubmed/32391121
http://dx.doi.org/10.18632/oncotarget.27566

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7197451/
https://www.ncbi.nlm.nih.gov/pubmed/32391121
http://dx.doi.org/10.18632/oncotarget.27566

Ejemplares similares